London-based US$46 billion-under-management private equity firm CVC Capital Partners is selling 186 million shares in China's Jintian Pharmaceutical Group for as much as HK$620 million (US$79.95 million), according to media reports. CVC is selling the shares in a range of HK$3.29 to HK$3.34 apiece, representing a 3.5% to 4.9% discount to the share's last closing […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.